January 10, 2018 M&A: 2017 proves snooze-worthy on the acquisition front Pharma and biotech takeover activity slumps to a five-year low in 2017.
January 08, 2018 Asia wins 2017’s mid-cap race A cooling of the M&A climate allows Asia-based groups to come to the fore.
October 05, 2017 Back to the future for small caps, but not all benefit Oncology-focused smaller biotechs reap rich rewards, but generics groups face hard times.